Kaps, L.; Nuhn, L.; Aslam, M. et al.
IN VIVO MYOFIBROBLAST SPECIFIC GENE SILENCING IN THE LIVER USING NOVEL SIRNA-LOADED BIODEGRADABLE NANOHYDROGEL PARTICLESJOURNAL OF HEPATOLOGY. Bd. 64. 2016 S. S448-S448
Schupp, J.; Foerster, F.; Bamberger, D. et al.
Initiation of anti-tumor immune responses by repolarisation of tumor associated macrophages using innovative nanoparticles as siRNA carriersEXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E19-E20
Peng, Zhen-Wei; Ikenaga, Naoki; Liu, Susan B. et al.
Integrin alpha v beta 6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesisHEPATOLOGY. Bd. 63. H. 1. 2016 S. 217-232
Liu, Susan B.; Ikenaga, Naoki; Peng, Zhen-Wei et al.
Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in miceFASEB JOURNAL. Bd. 30. H. 4. 2016 S. 1599-1609
Locatelli, Luigi; Cadamuro, Massimiliano; Spirli, Carlo et al.
Macrophage Recruitment by Fibrocystin-Defective Biliary Epithelial Cells Promotes Portal Fibrosis in Congenital Hepatic FibrosisHEPATOLOGY. Bd. 63. H. 3. 2016 S. 965-982
Hocher, Berthold; Haumann, Hannah; Rahnenfuehrer, Jan et al.
Maternal eNOS deficiency determines a fatty liver phenotype of the offspring in a sex dependent mannerEPIGENETICS. Bd. 11. H. 7. 2016 S. 539-552
Raker, Verena K.; Ook, Kim Y.; Haub, Jessica et al.
Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosisEXPERIMENTAL DERMATOLOGY. Bd. 25. H. 11. 2016 S. 887-894
Tuettenberg, Andrea; Steinbrink, Kerstin; Schuppan, Detlef
Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapyNANOMEDICINE. Bd. 11. H. 20. 2016 S. 2735-2751
Grabbe, Stephan; Landfester, Katharina; Schuppan, Detlef et al.
Nanoparticles and the immune system: challenges and opportunitiesNANOMEDICINE. Bd. 11. H. 20. 2016 S. 2621-2624
Pickert, Geethanjali; Becker, Christoph; Wirtz, Stefan et al.
Nutritional Wheat Alpha-Amylase/Trypsin Inhibitors Negatively Affect Intestinal Microbiota and Promote Intestinal Inflammation in MiceGASTROENTEROLOGY. Bd. 150. H. 4. 2016 S. S582-S582